Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Goodwill & Intangibles (2023 - 2025)

Envoy Medical's Goodwill & Intangibles history spans 3 years, with the latest figure at $7.5 million for Q2 2025.

  • On a quarterly basis, Goodwill & Intangibles changed N/A to $7.5 million in Q2 2025 year-over-year; TTM through Jun 2025 was $7.5 million, a N/A change, with the full-year FY2023 number at $10.0 million, changed N/A from a year prior.
  • Goodwill & Intangibles hit $7.5 million in Q2 2025 for Envoy Medical, roughly flat from $7.5 million in the prior quarter.
  • Over the last five years, Goodwill & Intangibles for COCH hit a ceiling of $10.0 million in Q4 2023 and a floor of $5.0 million in Q3 2023.
  • Historically, Goodwill & Intangibles has averaged $7.5 million across 3 years, with a median of $7.5 million in 2024.
  • The widest YoY moves for Goodwill & Intangibles: up 50.0% in 2024, down 50.0% in 2024.
  • Tracing COCH's Goodwill & Intangibles over 3 years: stood at $10.0 million in 2023, then fell by 25.0% to $7.5 million in 2024, then changed by 0.0% to $7.5 million in 2025.
  • Business Quant data shows Goodwill & Intangibles for COCH at $7.5 million in Q2 2025, $7.5 million in Q1 2025, and $7.5 million in Q3 2024.